Skip to main content

Advertisement

SpringerLink
Log in

Poised to branch out

  • News Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Although dendrimers have not yet taken the drug industry by storm, biomedical research and industrial applications of these tiny, highly branched molecules continue to grow. Vivien Marx reports.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: A conceptualization of DNA-linked dendrimers being internalized by a cell

References

  1. Mamikunian, V. & Maebius, S. Nanotech IP Battles Worth Fighting. (Lux Research, Foley & Lardner, New York, June 2006).

    Google Scholar 

  2. Lux Research. The Nanotech Report, 5th edn. (Lux Research, New York) 2007.

  3. Dobrovolskaia, M.A. et al. Molecular Pharmaceutics, published online, doi:10.1021/mp800032f, (30 May 2008).

    Article  CAS  Google Scholar 

  4. Swanson, D.R. et al. New J. Chem. 7, 1368–1378 (2007).

    Article  Google Scholar 

  5. Wiener, E.C. et al. Invest Radiol. 32, 748–54 (1997).

    Article  CAS  Google Scholar 

  6. Vetterlein, K. et al. Electrophoresis 28, 3088–3099 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. New York

    Vivien Marx

Authors
  1. Vivien Marx
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marx, V. Poised to branch out. Nat Biotechnol 26, 729–732 (2008). https://doi.org/10.1038/nbt0708-729

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0708-729

  • Springer Nature America, Inc.

Search

Navigation